# LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION

> **NCT07313982** · — · RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 350 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07313982
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-31
- **Primary completion:** 2026-02-28
- **Final completion:** 2027-08-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313982, "LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07313982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*